Monterde, Presevinda C.

HRN: 17-33-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
CEFUROXIME 1.5GM (VIAL)
11/17/2025
11/24/2025
IV
1.5g
Q8h
CAP-MR
Waiting Final Action 
11/17/2025
AZITHROMYCIN 500MG TABLET (TAB)
11/17/2025
11/21/2025
PO
500mg
Od
CAP-MR
Waiting Final Action 
11/19/2025
CEFTAZIDIME 1GM (VIAL)
11/19/2025
11/26/2025
IV
2g
Q8
Urosepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: